作者:
Bożena,Cybulska-Stopa [1]
;
Marcin,Ziętek [2]
;
Anna M,Czarnecka [3]
;
Karolina,Piejko [4]
;
Robert,Dziura [5]
;
Łukasz,Galus [1]
;
Barbara,Ziółkowska [6]
;
Stanisław,Kieszko [7]
;
Natasza,Kempa-Kamińska [8]
;
Jacek,Calik [9]
;
Joanna,Seredyńska [10]
;
Kamila,Gądek [11]
;
Tomasz,Zemełka [11]
;
Paweł,Teterycz [1]
;
Tomasz,Kubiatowski [1]
;
Rafał,Suwiński [1]
;
Jacek,Mackiewicz [4]
;
Piotr,Rutkowski [10]
作者单位:
Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Cracow Branch, Poland.
[1]
Department of Oncology, Wrocław Medical University, Wrocław, Poland.
[2]
Department of Surgical Oncology, Wrocław Comprehensive Cancer Center, Wrocław, Poland.
[3]
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
[4]
Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
[5]
Clinical Oncology Department, Holy Cross Cancer Center, Kielce, Poland.
[6]
Department of Medical and Experimental Oncology, University of Medical Sciences, Poznan, Poland.
[7]
Chemotherapy Department, Greater Poland Cancer Centre, Poznan, Poland.
[8]
II Clinic of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
[9]
Department of Clinical Oncology, Saint Jan of Dukla Oncology Centre of the Lublin Region, Lublin, Poland.
[10]
Department of Clinical Oncology, Wrocław Comprehensive Cancer Center, Wroclaw, Poland.
[11]
Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland.
[12]
DOI
10.1080/09546634.2021.1937477
PMID
34057374
发布时间
2022-07-06